Wave Life Sciences (WVE) Leases (2015 - 2026)

Wave Life Sciences (WVE) has 11 years of Leases data on file, last reported at $11.0 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 33.7% year-over-year to $11.0 million; the trailing twelve-month figure through Mar 2026 stood at $11.0 million (down 33.7% YoY), and the FY2025 full-year result was $12.5 million, down 30.29% from the prior year.
• Leases for Q1 2026 stood at $11.0 million, down from $12.5 million in the prior quarter.
• Across five years, Leases topped out at $27.8 million in Q3 2022 and bottomed at $11.0 million in Q1 2026.
• The 5-year median for Leases is $19.1 million (2024), against an average of $19.4 million.
• The widest annual swing landed in 2023, when Leases jumped 106.71%; it then sank 33.7% in 2026.
• A 5-year view of Leases shows it stood at $26.8 million in 2022, then slipped by 15.67% to $22.6 million in 2023, then retreated by 21.06% to $17.9 million in 2024, then slumped by 30.29% to $12.5 million in 2025, then decreased by 11.75% to $11.0 million in 2026.
• The last three Leases figures came in at $11.0 million (Q1 2026), $12.5 million (Q4 2025), and $13.9 million (Q3 2025), per Business Quant data.

Peer Comparison